Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,820 | 44,420 | 45,800 | 32,980 | 35,090 |
| Marketable Securities | 31,090 | 28,610 | 38,510 | 42,400 | 49,880 |
| Other current assets | 1,040 | 980 | 1,380 | 1,410 | 1,210 |
| TOTAL | $60,950 | $74,010 | $85,690 | $76,790 | $86,180 |
| Non-Current Assets | |||||
| PPE Net | 1,500 | 2,440 | 2,410 | 2,280 | 2,120 |
| Other Non-Current Assets | 8,770 | 9,080 | 9,410 | 9,530 | 9,840 |
| TOTAL | $10,270 | $11,520 | $11,820 | $11,810 | $11,960 |
| Total Assets | $70,110 | $84,230 | $96,290 | $87,470 | $97,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,490 | 600 | 890 | 800 | 540 |
| Accrued Expenses | 9,110 | 10,610 | 8,420 | 7,190 | 5,080 |
| TOTAL | $19,170 | $19,140 | $17,230 | $12,410 | $9,950 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,120 | 17,440 | 19,090 | 4,620 | 5,600 |
| TOTAL | $15,120 | $17,440 | $19,090 | $4,620 | $5,600 |
| Total Liabilities | $34,290 | $36,580 | $36,320 | $17,030 | $15,560 |
| Shareholders' Equity | |||||
| Common Shares | 690 | 690 | 690 | 690 | 690 |
| Retained earnings | -374,110 | -362,290 | -348,460 | -335,570 | -322,810 |
| Other shareholders' equity | 10 | 0 | 0 | 10 | 10 |
| TOTAL | $35,820 | $47,640 | $59,960 | $70,440 | $81,550 |
| Total Liabilities And Equity | $70,110 | $84,220 | $96,280 | $87,470 | $97,110 |